Literature DB >> 7777830

Correlations between PAF-acether and tumor necrosis factor in rheumatoid arthritis. Influence of parenteral corticosteroids.

P Hilliquin1, H Houbaba, J Aissa, J Benveniste, C J Menkes.   

Abstract

The aim of this study was to evaluate the presence of PAF-acether (PAF), its specific degrading enzyme acetylhydrolase, and tumor necrosis factor (TNF) concentrations in blood and synovial fluid (SF) from patients with active RA. The variations of the mediators were also evaluated after corticosteroid perfusions in 7 patients. Lipo-PAF (PAF complexed to lipoproteins) was the main form of PAF detected both in blood and in SF, whereas unbound PAF was uncommon. Acetylhydrolase activity was also present in SF, with a strong correlation between serum and SF levels. TNF was detected in most of the samples, and TNF and acetylhydrolase levels were strongly correlated both in blood and in SF. Despite dramatic clinical improvement, corticosteroid treatment was not accompanied by a significant reduction of the concentration of blood mediators, suggesting that these molecules should not be considered as markers of disease activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7777830     DOI: 10.3109/03009749509099308

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  4 in total

Review 1.  Current Understanding of Platelet-Activating Factor Signaling in Central Nervous System Diseases.

Authors:  Yulong Liu; Lisa B E Shields; Zhongwen Gao; Yuanyi Wang; Yi Ping Zhang; Tianci Chu; Qingsan Zhu; Christopher B Shields; Jun Cai
Journal:  Mol Neurobiol       Date:  2016-09-09       Impact factor: 5.590

2.  Effects of Platelet-Activating Factor on Brain Microvascular Endothelial Cells.

Authors:  Eugen Brailoiu; Christine L Barlow; Servio H Ramirez; Mary E Abood; G Cristina Brailoiu
Journal:  Neuroscience       Date:  2018-03-06       Impact factor: 3.590

3.  Atherosclerosis assessment and rheumatoid arthritis.

Authors:  C Bes; S Gürel; G Buğdaycı; O Dikbaş; M Soy
Journal:  Z Rheumatol       Date:  2018-05       Impact factor: 1.372

4.  Decreased levels of serum platelet-activating factor acetylhydrolase in patients with rheumatic diseases.

Authors:  P Vergne; V Praloran; R Treves; Y Denizot
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.